LifeVantage Corporation has extended its MindBody GLP-1 System into international markets. The system’s success in the US has been credited with the company’s recent 49% year-over-year increase in revenue during the second quarter of the fiscal year.

LifeVantage Corporation announced the launch of the Evolve Compensation Plan and other LV360 initiatives in the Philippines, Taiwan, Hong Kong and Singapore. This Phase 3 expansion went into effect at the beginning of March 2025 and follows a successful launch of LV360 in Canada, Mexico and Europe in February and its launch in the US, […]

The direct selling industry is a mystery to many people, especially lawmakers who often equate it with negative stereotypes of the past rather than recognizing the positive impact it has on state and local economies. Who better to explain all the positive attributes of direct selling than the companies themselves?

LifeVantage released its financial results for the second quarter of fiscal 2025. Revenue during the quarter reached $67.8 million, an increase of 31.3% year-over-year.

LifeVantage Corporation announced it has completed an international study of its MindBody GLP-1 System. The in vitro cell study used Enzyme-Linked Immunosorbent Assay (ELISA) to measure total GLP-1 production and used fluorescent microscopy to visualize outcomes.

LifeVantage Corporation and its TrueScience Activated Skincare Collection was recognized with a silver award for Most Innovative Product Line at the Best in Biz Awards 2024.

A third-party cell study provided new insights into the synergistic impact of LifeVantage Corporation’s Protandim Nrf2 Synergizer and the MindBody GLP-1 System. When used in combination, the study revealed, the products were shown to not only amplify each other’s benefits, but also activate 22 new genes that can help organs stay structurally sound and support cell regeneration and repair.

LifeVantage Corporation has declared 2025 its “Drive ERA.” Thousands of LifeVantage Consultants joined the company at its annual Global Kickoff, where the company detailed its vision for the new year.

LifeVantage announced its preliminary financial results for the second quarter of fiscal 2025. Revenue increased by 31% from the prior year period and 43% sequentially to $67.5 million.

LifeVantage announced its first quarter financial results for fiscal 2025. Revenue was $47.2 million, an 8.1% decrease from the prior year period, with revenue in the Americas declining 4.2%. Asia Pacific & Europe saw a 19.7% decline in revenue.

LifeVantage Corporation announced the US launch of its patent-pending MindBody GLP-1 System. The dual-product system is intended to help consumers reduce their cravings and support sustainable weight management by balancing hunger hormones.

In an effort to simplify its compensation plan structure, LifeVantage Corporation announced an enhancement to its Evolve Compensation Plan that will pay consultants a 10% commission for sharing its products.